» Articles » PMID: 12831818

A Prospective Survey of Patients with Valvular Heart Disease in Europe: The Euro Heart Survey on Valvular Heart Disease

Overview
Journal Eur Heart J
Date 2003 Jul 2
PMID 12831818
Citations 833
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To identify the characteristics, treatment, and outcomes of contemporary patients with valvular heart disease (VHD) in Europe, and to examine adherence to guidelines.

Methods And Results: The Euro Heart Survey on VHD was conducted from April to July 2001 in 92 centres from 25 countries; it included prospectively 5001 adults with moderate to severe native VHD, infective endocarditis, or previous valve intervention. VHD was native in 71.9% of patients and 28.1% had had a previous intervention. Mean age was 64+/-14 years. Degenerative aetiologies were the most frequent in aortic VHD and mitral regurgitation while most cases of mitral stenosis were of rheumatic origin. Coronary angiography was used in 85.2% of patients before intervention. Of the 1269 patients who underwent intervention, prosthetic replacement was performed in 99.0% of aortic VHD, percutaneous dilatation in 33.9% of mitral stenosis, and valve repair in 46.5% of mitral regurgitation; 31.7% of patients had > or =1 associated procedure. Of patients with severe, symptomatic, single VHD, 31.8% did not undergo intervention, most frequently because of comorbidities. In asymptomatic patients, accordance with guidelines ranged between 66.0 and 78.5%. Operative mortality was <5% for single VHD.

Conclusions: This survey provides unique contemporary data on characteristics and management of patients with VHD. Adherence to guidelines is globally satisfying as regards investigations and interventions.

Citing Articles

Managing Commissural Mitral Valve Regurgitation Following Transcatheter Mitral Valve Repair Using the Amplatzer Occluder Device.

Zughaib M, Patel H, Assaf A, Saba S, Alexander P Cureus. 2025; 17(2):e78507.

PMID: 40062032 PMC: 11885197. DOI: 10.7759/cureus.78507.


Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease.

Yu Y, Jiang Q Cardiol Res. 2025; 16(2):86-101.

PMID: 40051666 PMC: 11882237. DOI: 10.14740/cr2012.


Transfemoral Transcatheter Aortic Valve Implantation at Hospitals Without On-Site Cardiac Surgery (TAVI at Home): A Multicenter Prospective Interventional Study.

Compagnone M, DallAra G, Grotti S, Mambelli G, Fabbri E, Savini C J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997497 PMC: 11856494. DOI: 10.3390/jcdd12020063.


The Prognostic Value of Platelet-Albumin-Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement.

Duan X, Qu L, Chen H Clin Cardiol. 2025; 48(3):e70100.

PMID: 39992725 PMC: 11849681. DOI: 10.1002/clc.70100.


Sex-related hormonal variances and clinical outcomes in TAVR patients.

Mousa Basha M, Al-Kassou B, Weber M, Beiert T, Bakhtiary F, Zimmer S Clin Res Cardiol. 2025; .

PMID: 39992388 DOI: 10.1007/s00392-025-02623-6.